Physician profile
Edwin R Roman
NPI 1407871700
$5,984.33
in general payments reported to CMS, 2019-2025
14 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,377 · 2020: $19.75 · 2021: $3,740 · 2022: $217 · 2023: $71.64 · 2024: $195 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.43 |
| Education | $128.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $3,587.15 | 2019-2021 | |
| Smith+Nephew, INC. | $1,385.13 | 2019-2023 | Grafix Pl, Stravix Pl |
| Paratek Pharmaceuticals, INC. | $283.83 | 2024-2025 | Nuzyra |
| Kerecis Limited | $131.87 | 2020-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Djo, LLC | $128.00 | 2025 | Dr Comfort |
| Kowa Pharmaceuticals America, INC. | $115.64 | 2022-2023 | Seglentis |
| Amgen INC. | $91.29 | 2021 | |
| Sandoz INC. | $69.46 | 2019 | |
| Stryker Corporation | $63.46 | 2022-2023 | Hydroset |
| Treace Medical Concepts, INC. | $59.45 | 2022-2025 | |
| Aroa Biosurgery Incorporated | $22.33 | 2022 | |
| Integra Lifesciences Corporation | $16.64 | 2022 | |
| Hartmann USA, INC. | $15.40 | 2021 | |
| Horizon Therapeutics Plc | $14.68 | 2023 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Roman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.